Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

NCT02707315 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT02707315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02707315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Lead sponsor
The Cooper Health System
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2013
Completion date
Not reported
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the pancreas, pancreas adenocarcinoma, pancreas cancer, pancreatic adenocarcinoma, pancreatic cancer